XFRA CAPITAL ADJUSTMENT INFORMATION

Realtime	Geld	Brief	Zeit
	0,000	0,000	16.10.

Realtime

Geld

Brief

Zeit

0,000

16.10.

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024

Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument TG4 BE0003846632 OXURION N.V. EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument TG4 BE0003846632 OXURION N.V. EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument 5LH0 SE0021181559 GUARD THERAPEUTICS INT.AB EQUITY wird ex Kapitalmassnahme gehandelt am 02.09.2024
The instrument 5LH0 SE0021181559 GUARD THERAPEUTICS INT.AB EQUITY is traded ex capital adjustment on 02.09.2024

Das Instrument HQ10 US00211Y5069 ARCA BIOPHARMA DL-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument HQ10 US00211Y5069 ARCA BIOPHARMA DL-,01 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument FET KYG3307Z1090 FAR EAST CONS. INTL HD-10 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument FET KYG3307Z1090 FAR EAST CONS. INTL HD-10 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument 4QI KYG982771092 XTEP INTL HOL.REGS HD-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument 4QI KYG982771092 XTEP INTL HOL.REGS HD-,01 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument 6LJ US5768101058 MATINAS BIOPH.HLD.DL-,001 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument 6LJ US5768101058 MATINAS BIOPH.HLD.DL-,001 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument M5L GB00B0MT3Y97 MATTIOLI WOODS PLC LS-,01 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024
The instrument M5L GB00B0MT3Y97 MATTIOLI WOODS PLC LS-,01 EQUITY is traded cum capital adjustment on 02.09.2024 and ex capital adjustment on 03.09.2024

Das Instrument EJ7 AU000000ERA9 ENERGY RES. A EQUITY wird ex Kapitalmassnahme gehandelt am 02.09.2024
The instrument EJ7 AU000000ERA9 ENERGY RES. A EQUITY is traded ex capital adjustment on 02.09.2024

Treibt Nvidias KI-Boom den Uranpreis?

In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.

Hier klicken

Zeit	Aktuelle Nachrichten
08:59	ENERGY RESOURCES OF AUSTRALIA LIMITED: Change in substantial holding from RIO
00:36	ENERGY RESOURCES OF AUSTRALIA LIMITED: Appendix 2A - application for quotation of securities
Mi	Rio Tinto takes full control at Energy Resources of Australia
Di	Rio Tinto owns 98% of ERA after taking full entitlement in rights issue
Di	Rio Tinto takes full entitlement in ERA rights issue, securing 98% ownership: Diversified miner Rio Tinto has taken up its ...

Zeit

Aktuelle Nachrichten

08:59

ENERGY RESOURCES OF AUSTRALIA LIMITED: Change in substantial holding from RIO

00:36

ENERGY RESOURCES OF AUSTRALIA LIMITED: Appendix 2A - application for quotation of securities

Rio Tinto takes full control at Energy Resources of Australia

Rio Tinto owns 98% of ERA after taking full entitlement in rights issue

Rio Tinto takes full entitlement in ERA rights issue, securing 98% ownership: Diversified miner Rio Tinto has taken up its ...

Zeit	Aktuelle Nachrichten
13:00	FE CONSORT INTL (00035): PROFIT WARNING
Mo	FE CONSORT INTL (00035): DATE OF BOARD MEETING
24.10.	FE CONSORT INTL (00035): NEXT DAY DISCLOSURE RETURN
30.09.	FE CONSORT INTL (00035): CONTINUING CONNECTED TRANSACTIONS HOTEL MANAGEMENT CONTRACTS AND TRADEMARK LICENSE AGREEMENTS IN RELATION TO HOTELS IN MALAYSIA
23.09.	FE CONSORT INTL (00035): SETTLEMENT OF CONSENT SOLICITATION - U.S.$360,000,000 SENIOR GUARANTEED PERPETUAL CAPITAL NOTES ISSUED BY FEC FINANCE LIMITED ...

Zeit

Aktuelle Nachrichten

13:00

FE CONSORT INTL (00035): PROFIT WARNING

FE CONSORT INTL (00035): DATE OF BOARD MEETING

24.10.

FE CONSORT INTL (00035): NEXT DAY DISCLOSURE RETURN

30.09.

FE CONSORT INTL (00035): CONTINUING CONNECTED TRANSACTIONS HOTEL MANAGEMENT CONTRACTS AND TRADEMARK LICENSE AGREEMENTS IN RELATION TO HOTELS IN MALAYSIA

23.09.

FE CONSORT INTL (00035): SETTLEMENT OF CONSENT SOLICITATION - U.S.$360,000,000 SENIOR GUARANTEED PERPETUAL CAPITAL NOTES ISSUED BY FEC FINANCE LIMITED ...

Zeit	Aktuelle Nachrichten
04.09.	Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Guard Therapeutics International AB	With effect from September 05, 2024, the subscription rights in Guard Therapeutics International AB will be traded on First North Growth Market. Trading will continue up until and including September... ► Artikel lesen
02.09.	XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024	Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024 The instrument MSPA MA0000011488 ITISSALAT AL-MA.... ► Artikel lesen
29.08.	Guard Therapeutics International AB: First patient dosed in Guard Therapeutics' phase 2b study POINTER	Guard Therapeutics today announced that the first patient has been dosed in the phase 2b clinical study POINTER with the drug candidate RMC-035 as a kidney-protective treatment in open-heart surgery. "It... ► Artikel lesen
27.08.	Guard Therapeutics International AB: Guard Therapeutics carries out announced rights issue (repair issue)	THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, DISTRIBUTED OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA... ► Artikel lesen

Zeit

Aktuelle Nachrichten

04.09.

Nasdaq Stockholm AB: Listing of subscription rights and paid subscription shares of Guard Therapeutics International AB

With effect from September 05, 2024, the subscription rights in Guard Therapeutics International AB will be traded on First North Growth Market. Trading will continue up until and including September...
► Artikel lesen

02.09.

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024

29.08.

Guard Therapeutics International AB: First patient dosed in Guard Therapeutics' phase 2b study POINTER

Guard Therapeutics today announced that the first patient has been dosed in the phase 2b clinical study POINTER with the drug candidate RMC-035 as a kidney-protective treatment in open-heart surgery. "It...
► Artikel lesen

27.08.

Guard Therapeutics International AB: Guard Therapeutics carries out announced rights issue (repair issue)

THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, DISTRIBUTED OR PUBLISHED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA...
► Artikel lesen

Zeit	Aktuelle Nachrichten
02.09.	XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024		Das Instrument MSPA MA0000011488 ITISSALAT AL-MA. INH.DH 6 EQUITY wird cum Kapitalmassnahme gehandelt am 02.09.2024 und ex Kapitalmassnahme am 03.09.2024 The instrument MSPA MA0000011488 ITISSALAT AL-MA.... ► Artikel lesen
10.07.	The Court's Response to Maroc Telecom's Appeal Hinders the Success of e&'s Investments in Morocco		ABU DHABI, UAE, July 10, 2024 /PRNewswire/ -- e& Group has expressed its disappointment with the Court of Appeal of Casablanca's decision on 3 July 2024, which rejected the appeal filed by... ► Artikel lesen

Zeit

Aktuelle Nachrichten

02.09.

XFRA CAPITAL ADJUSTMENT INFORMATION - 02.09.2024

10.07.

The Court's Response to Maroc Telecom's Appeal Hinders the Success of e&'s Investments in Morocco

ABU DHABI, UAE, July 10, 2024 /PRNewswire/ -- e& Group has expressed its disappointment with the Court of Appeal of Casablanca's decision on 3 July 2024, which rejected the appeal filed by...
► Artikel lesen

Zeit	Aktuelle Nachrichten
13.11.	Matinas BioPharma Holdings, Inc. - 10-Q, Quarterly Report
06.11.	MTNB stock touches 52-week low at $0.5 amid sharp annual decline
06.11.	MTNB-Aktie erreicht 52-Wochen-Tief bei 0,5 US-Dollar
31.10.	Matinas BioPharma mulls wind-down as antifungal therapy deal falls through
31.10.	Matinas BioPharma plunges as deal for lead asset falls apart

Zeit

Aktuelle Nachrichten

13.11.

Matinas BioPharma Holdings, Inc. - 10-Q, Quarterly Report

06.11.

MTNB stock touches 52-week low at $0.5 amid sharp annual decline

06.11.

MTNB-Aktie erreicht 52-Wochen-Tief bei 0,5 US-Dollar

31.10.

Matinas BioPharma mulls wind-down as antifungal therapy deal falls through

31.10.

Matinas BioPharma plunges as deal for lead asset falls apart

Zeit	Aktuelle Nachrichten
Di	Mattioli Woods: Profit slashed at wealth manager as it quit London
04.09.	AIM - Cancellation - MATTIOLI WOODS PLC
03.09.	Mattioli Woods PLC - Scheme Effective
03.09.	AIM - Suspension - Mattioli Woods plc
02.09.	XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.09.2024	The following instruments on Boerse Frankfurt do have their last trading day on 02.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.09.2024ISIN NameBE0003846632 OXURION... ► Artikel lesen

Zeit

Aktuelle Nachrichten

Mattioli Woods: Profit slashed at wealth manager as it quit London

04.09.

AIM - Cancellation - MATTIOLI WOODS PLC

03.09.

Mattioli Woods PLC - Scheme Effective

03.09.

AIM - Suspension - Mattioli Woods plc

02.09.

XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.09.2024

The following instruments on Boerse Frankfurt do have their last trading day on 02.09.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.09.2024ISIN NameBE0003846632 OXURION...
► Artikel lesen

Zeit	Aktuelle Nachrichten
14.11.	Oruka Therapeutics, Inc. - 8-K, Current Report
14.11.	Oruka Therapeutics files to sell 8.72M shares of common stock for holders
14.11.	Oruka Therapeutics, Inc. - S-1, General form for registration of securities
14.11.	Oruka Therapeutics GAAP EPS of -$1.46 misses by $1.08
13.11.	Oruka Therapeutics, Inc.: Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update	Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical inflection points ORKA-001 non-human primate (NHP) pharmacokinetic and in vitro... ► Artikel lesen

Zeit

Aktuelle Nachrichten

14.11.

Oruka Therapeutics, Inc. - 8-K, Current Report

14.11.

Oruka Therapeutics files to sell 8.72M shares of common stock for holders

14.11.

Oruka Therapeutics, Inc. - S-1, General form for registration of securities

14.11.

Oruka Therapeutics GAAP EPS of -$1.46 misses by $1.08

13.11.

Oruka Therapeutics, Inc.: Oruka Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Successful go-public transaction and over $475 million raised this year provides cash runway through multiple clinical inflection points ORKA-001 non-human primate (NHP) pharmacokinetic and in vitro...
► Artikel lesen

Zeit	Aktuelle Nachrichten
14.11.	OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC	Leuven, BELGIUM - November 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen
05.11.	OXURION: Oxurion terminates its Private Judicial Reorganization Procedure following amicable settlement agreements	Leuven, Belgium - November 5, 2024 - 10:30 AM CET - Oxurion NV (Euronext Brussels: OXUR) announces that it terminated the private judicial reorganization (PRJ) procedure initiated on August 22... ► Artikel lesen
29.10.	OXURION: Oxurion NV: Key developments and timeline for current the potential acquisition	Oxurion NV: Belangrijkste ontwikkelingen en lijn met betrekking tot de lopende potentiële overname LEUVEN, BELGIË - 29 oktober 2024 - 22u00 CET, Oxurion NV (Euronext Brussels: OXUR), een biofarmaceutisch... ► Artikel lesen
24.10.	OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC	Leuven, BELGIUM - October 24, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen
14.10.	OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC	Leuven, BELGIUM - October 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency... ► Artikel lesen

Zeit

Aktuelle Nachrichten

14.11.

OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM - November 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

05.11.

OXURION: Oxurion terminates its Private Judicial Reorganization Procedure following amicable settlement agreements

Leuven, Belgium - November 5, 2024 - 10:30 AM CET - Oxurion NV (Euronext Brussels: OXUR) announces that it terminated the private judicial reorganization (PRJ) procedure initiated on August 22...
► Artikel lesen

29.10.

OXURION: Oxurion NV: Key developments and timeline for current the potential acquisition

Oxurion NV: Belangrijkste ontwikkelingen en lijn met betrekking tot de lopende potentiële overname LEUVEN, BELGIË - 29 oktober 2024 - 22u00 CET, Oxurion NV (Euronext Brussels: OXUR), een biofarmaceutisch...
► Artikel lesen

24.10.

OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM - October 24, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

14.10.

OXURION: Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Leuven, BELGIUM - October 14, 2024 - 06:00 PM CET - Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today announced that, pursuant to Belgian Transparency...
► Artikel lesen

Zeit	Aktuelle Nachrichten
08.11.	Chinese sports brand Xtep debuts in Malaysia
01.11.	XTEP INT'L (01368): (1) COMPLETION OF ISSUE OF XTEP CONVERTIBLE BONDS; (2) COMPLETION OF EARLY REDEMPTION OF K-SWISS CONVERTIBLE BONDS BY KP GLOBAL AND ...
30.10.	XTEP INT'L (01368): NEXT DAY DISCLOSURE RETURNS
30.10.	XTEP INT'L (01368): ADJUSTMENT TO CONVERSION PRICE OF THE CONVERTIBLE BONDS
23.10.	Core XTEP INT'L Brand 3Q Retail Sell-through Records Mid-single Digit YoY Growth

Zeit

Aktuelle Nachrichten

08.11.

Chinese sports brand Xtep debuts in Malaysia

01.11.

XTEP INT'L (01368): (1) COMPLETION OF ISSUE OF XTEP CONVERTIBLE BONDS; (2) COMPLETION OF EARLY REDEMPTION OF K-SWISS CONVERTIBLE BONDS BY KP GLOBAL AND ...

30.10.

XTEP INT'L (01368): NEXT DAY DISCLOSURE RETURNS

30.10.

XTEP INT'L (01368): ADJUSTMENT TO CONVERSION PRICE OF THE CONVERTIBLE BONDS

23.10.

Core XTEP INT'L Brand 3Q Retail Sell-through Records Mid-single Digit YoY Growth

Unternehmen / Aktien	Kurs	%
ENERGY RESOURCES OF AUSTRALIA LIMITED	0,002	0,00 %
FAR EAST CONSORTIUM INTERNATIONAL LTD	0,115	0,00 %
GUARD THERAPEUTICS INTERNATIONAL AB	1,610	0,00 %
MAROC TELECOM	7,600	-0,65 %
MATINAS BIOPHARMA HOLDINGS INC	0,572	0,00 %
MATTIOLI WOODS PLC	9,250	0,00 %
ORUKA THERAPEUTICS INC	20,800	0,00 %
OXURION NV	0,271	+0,93 %
XTEP INTERNATIONAL HOLDINGS LTD	0,640	0,00 %

Unternehmen / Aktien

Kurs

ENERGY RESOURCES OF AUSTRALIA LIMITED

0,002

0,00 %

FAR EAST CONSORTIUM INTERNATIONAL LTD

0,115

0,00 %

GUARD THERAPEUTICS INTERNATIONAL AB

1,610

0,00 %

MAROC TELECOM